Showing results (271-280 of 462) with videos related to
Sort By:
Pageof 47
Toxicology|November 8, 2016
Hesperitin derivative-11 suppress hepatic stellate cell activation and proliferation by targeting PTEN/AKT pathwayWan-Xia Li, Xin Chen, Yang Yang, et al.Biomolecules|August 26, 2022
Advancements in the Alcohol-Associated Liver Disease ModelLin Zhu, Hai-Di Li, Jie-Jie Xu, et al.The Journal of Pathology|December 23, 2011
Diverse roles of TGF-β receptor II in renal fibrosis and inflammation in vivo and in vitroXiao-Ming Meng, Xiao Ru Huang, Jun Xiao, et al.Cellular Signalling|January 21, 2014
Promising roles of mammalian E2Fs in hepatocellular carcinomaLei Zhan, Cheng Huang, Xiao Ming Meng, et al.Liver International : Official Journal of the International Association for the Study of the Liver|August 4, 2020
LncRNA NEAT1: Shedding light on mechanisms and opportunities in liver diseasesFang-Tian Bu, Ao Wang, Yan Zhu, et al.Journal of Hazardous Materials|April 4, 2009
Characterization and photocatalytic property of Pd/TiO2 with the oxidation of gaseous benzeneJun Bo Zhong, Yan Lu, Wei Dong Jiang, et al.British Journal of Pharmacology|October 5, 2022
RNA N6 -methyladenosine modifications and potential targeted therapeutic strategies in kidney diseaseWei-Jian Ni, Hao Lu, Nan-Nan Ma, et al.Journal of Physiology and Biochemistry|November 28, 2015
Inhibition of IRF3 expression reduces TGF-β1-induced proliferation of hepatic stellate cellsMing-ming Ni, Tao Xu, Ya-rui Wang, et al.International Immunopharmacology|June 8, 2019
Inhibitory effects of octreotide on the progression of hepatic fibrosis via the regulation of Bcl-2/Bax and PI3K/AKT signaling pathwaysChong Zhang, Ran An, Ya-Wei Bao, et al.Kidney Diseases (Basel, Switzerland)|October 4, 2021
Smad3-Targeted Therapy Protects against Cisplatin-Induced AKI by Attenuating Programmed Cell Death and Inflammation via a NOX4-Dependent MechanismQin Yang, Li Gao, Xiao-Wei Hu, et al.Pageof 47